Related Experiment Video

Updated: May 8, 2026

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma
09:52

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma

Published on: January 25, 2015

Current and emerging treatment options for uveal melanoma

Patricia Rusa Pereira1, Alexandre Nakao Odashiro, Li-Anne Lim

  • 1The Henry C Witelson Ocular Pathology Laboratory, McGill University, Montreal, QC, Canada.

Clinical Ophthalmology (Auckland, N.Z.)
|September 5, 2013
PubMed

Insights

Uveal melanoma (UM), a common eye cancer, frequently metastasizes to the liver. This review discusses current and emerging treatments for metastatic UM, addressing the urgent need for effective systemic therapies.

Area of Science:

  • Ophthalmology
  • Oncology
  • Medical Research

Background:

  • Uveal melanoma (UM) is the most common primary intraocular malignancy in adults.
  • UM has a significant 10-year cumulative metastatic rate of 34%, predominantly to the liver (95%).
  • Metastatic UM has limited effective systemic treatment options and a poor prognosis.

Purpose of the Study:

  • To review current therapeutic strategies for uveal melanoma.
  • To summarize promising novel treatments for metastatic uveal melanoma.
  • To highlight the challenges in managing advanced-stage uveal melanoma.

Main Methods:

  • Literature review of current and emerging treatments for uveal melanoma.
  • Analysis of treatment outcomes and survival data for metastatic UM.
  • Synthesis of information on management of primary and metastatic disease.

Main Results:

  • Current treatments for primary UM include surgery and conservative methods.
  • Management of metastatic UM lacks a standard approach.
  • Median survival after liver metastasis is poor (4-6 months), with low 1-year survival rates (10%-15%).

Conclusions:

  • There is a critical need for effective systemic therapies for metastatic uveal melanoma.
  • Ongoing research focuses on developing novel treatment modalities.
  • Improved treatment strategies are essential to enhance survival for patients with advanced UM.
Keywords:
choroidal melanomaeyemetastasistherapytreatmentuveal melanoma

More Related Videos

Implantation and Evaluation of Melanoma in the Murine Choroid via Optical Coherence Tomography05:46

Implantation and Evaluation of Melanoma in the Murine Choroid via Optical Coherence Tomography

Published on: December 2, 2022

Related Concept Videos

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...